The Need for and Design of Combination Vaccines


Combination vaccines, by increasing the number of antigens that can be delivered at a single visit, will dramatically extend the range of diseases preventable by childhood immunization. As the antigenic possibilities and researchers’ technical capabilities increase, the rational design and development of combination vaccines become especially complex. A variety of epidemiological, medical, physicochemical, and commercial considerations are taken into account by manufacturers in determining which set(s) of antigens make “sense “ as combinations. A key challenge will be to predict and/or influence which antigens will be recommended for inclusion in the infant schedules in key markets in the coming years. Resource constraints dictate that companies must minimize the numbers of combinations to be developed, while at the same time offer combinations appropriate to different markets around the globe.


  1. 1.

    Baker PJ, ed. The Jordan Report: Accelerated development of vaccines, 1996. Bethesda, MD: U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health; 1996.

    Google Scholar 

  2. 2.

    Hausdorff WP, Paradiso PR. International Experience with IPV and OPV: Lessons for the U.S. Abstract #119, Presented at 31st Annual National Immunization Conference, Detroit, MI, May 19–22, 1997.

    Google Scholar 

  3. 3.

    Dobson S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B vaccination program. JAMA. 1995;274(15):1242–1243.

    Article  Google Scholar 

  4. 4.

    Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. Infect Dis. 1995; 171:885–889.

    CAS  Article  Google Scholar 

  5. 5.

    Rossi A, Ruvinski R, Regueira M, Corso A, Pace J, Gentile A, DiFabio JL, the Streptococcus pneumoniae Working Group. Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Microbial Drug Resist. 1997;3(2):135–140.

    CAS  Article  Google Scholar 

  6. 6.

    Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect. 1996;117:411–416.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Dr. William P. Hausdorff PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hausdorff, W.P. The Need for and Design of Combination Vaccines. Ther Innov Regul Sci 32, 13–17 (1998).

Download citation

Key Words

  • Combination vaccines
  • Pediatric immunization
  • Vaccine strategy